Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 32, 2002 - Issue 2
151
Views
11
CrossRef citations to date
0
Altmetric
Research Article

LC-MS-MS analysis of hydromorphone and hydromorphone metabolites with application to a pharmacokinetic study in the male Sprague-Dawley rat

, &
Pages 141-151 | Published online: 22 Sep 2008

References

  • BABuL, N., DARKE, A. C. and HAGE N., 1995, Hydromorphone metabolite accumulation in renal failure. Journal of Pain Symptoms and Management, 10, 184–186.
  • BOUQUILLON, A. I., FREEMAN, D. and MOULIN, D. E., 1992, Simultaneous solid-phase extraction and chromatographic analysis of morphine and hydromorphone in plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography, 577, 354–357.
  • BRUERA, E., MACEACHERN, T., MACMILLAN, K., MILLER, M. J. and HANSON, J., 1993, Local tolerance to subcutaneous infusions of high concentrations of hydromorphone: a prospective study. Journal of Pain Symptoms and Management, 8, 201–204.
  • BRUERA, E., SLOAN, P., MOUNT, B., SCOTT, J. and SUAREZ-ALMAZOR, M., 1996, A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patient with cancer pain. Journal of Clinical Oncology, 14, 1713–1717.
  • BUDAVARI, S., O'NEIL, M. J., SMITH, A., HECKELMAN, P. E. and KINNEARY, J. F. (eds), 1996, The Merck Index, 12th edn (Whitehouse Station: Merck), pp. 824, 1074.
  • CHANG, S. F., MOORE, L. and CHIEN, Y. W., 1988, Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration. Pharmaceutical Research, 5, 718–721.
  • CODA, B., TANAKA, A., JACOBSON, R. C., DONALDSON, G. and CHAPMAN, C. R., 1997, Compara-tive efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain, 72, 333–346.
  • CONE, E. J., PHELPS, B. A. and GORODETZKY, C. W., 1977, Urinary extraction of hydromorphone and metabolites in humans, rats, dogs, guinea pigs and rabbits. Journal of Pharmaceutical Sciences, 66, 1709–1713.
  • DUNBAR, P. J., BUCKLEY, P., GAVRIN, J. R., SANDERS, J. E. and CHAPMAN, C. R., 1995, Use of patient-controlled analgesia for pain control for children receiving bone marrow transplant. Journal of Pain Symptoms and Management, 10, 604–611.
  • GAETA, R. R., MACARIO, A., BRODSKY, J. B., BROCK-UTNE, J. G. and MARK, J. B. D., 1995, Pain outcomes after thoracotomy lumber epidural hydromorphone versus intrapleural bupivacaine. Journal of Cardiothorack and Vascular Anesthesia, 9, 534–537.
  • GIBALDI, M. and PERRIER, D., 1982, Pharmacokinetics (New York: Marcel Dekker).
  • HAGEN, N., THIRLWELL, M. P., DHALIWAL, H. S., BABUL, N., HARSANYI, Z. and DARKE, A. C., 1995, Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone. Journal of Clinical Pharmacology, 35, 37–44.
  • HALPERN, S. H., ARELLANO, R., PRESTON, R., CARSTONIU, J., O'LEARY, G., ROGER, S. and SANDLER, A., 1996, Epidural morphine vs hydromorphone in post-caesarean section patients. Canadian Journal of Anaesthesia, 43, 595–598.
  • HILL, H. F., CODA, B. A., TANAKA, A. and SCHAFFE R., 1991, Multiple-dose evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects. Anesthesia and Analgesia, 72, 330–336.
  • HONIGBERG, I. L. and STEWART, J. T., 1980, Radioumrnunoassay of hydromorphone and hydrocodone in human plasma. Journal of Pharmaceutical Sciences, 69, 1171–1173.
  • HOUDE, R. W., 1986, Clinical analgesic studies of hydromorphone. Advances in Pain Research Therapy, 8, 129–135.
  • LAWLOR, P., TURNER, K., HANSON, J. and BRUERA, E., 1997, Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain, 72, 79–85.
  • LEE, J. W., PEDERSEN, J. E., MORAVETZ, T. L., DZERK, A. M., MUNDT, A. D. and SHEPARD, K. V., 1991, Sensitive and specific radioirnmunoassays for opiates using commercially available materials. I: Methods for the determinations of morphine and hydromorphone. Journal of Pharmaceutical Science, 80, 284–288.
  • MENON, S. K., BuFaLETT, M. K. and JOSEPH, J. C., 1989, High performance liquid chromatography assay of hydromorphone hydrochloride injection. Journal of Liquid Chromatography, 12, 657–671.
  • PACIFICI, R., PICHINI, S., ALTIERI, I., CARONNA, A., PASSA, A. R. and ZUCCARO, P., 1995, High-performance liquid chromatographic-electrospray mass spectrometric determination of morphine and its 3- and 6-glucuronides: application to pharmacokinetic studies. Journal of Chromatography B, 664, 329–334.
  • PARAB, P. V., RITSCHEL, W. A., COYLE, D. E., GREGG, R. V. and DENSON, D. D., 1988, Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administraton to human subjects. Biopharmaceutics and Drug Disposition, 9, 187–199.
  • RAPP, S. E., EGAN, K. J., Ross, B. K., WILD, L. M., TERMAN, G. W. and CHING, J. M., 1996, A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. Anesthesia and Analgesia, 82, 1043–1048.
  • RITSCHEL, W. A., PARAB, P. V., DENSON, D. D., COYLE, D. E. and GREGG, R. V., 1987, Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/ plasma ratio and clinical effects. Journal of Clinical Pharmacology, 27, 647–653.
  • ROLAND, M. and TOPAZ, T. N., 1995, Clinical Pharmacokinetics: Concepts and Applications (Media: Williams & Wilkins), pp. 367.
  • SAADY, J. J., NARASIMHACHARI, N. and BLANKE, R. V., 1982, Rapid, simultaneous quantification of morphine, codeine and hydromorphone by GC/MS. Journal of Analytical Toxicology, 6, 235–237.
  • SEARLE, N. R., ROY, M., BERGERON, G., PERRAULT, J., Roo, J., HEERMANS, C., COURTEMANCHE, M., DEMERS, C. and CARTIE R., 1994, Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery. Canadian Journal of Anaesthesia, 41, 198–205.
  • SMITH, M. L., HUGHES, R. 0., LEVINE, B., DICKERSON, S., DARWIN, W. D. and CONE, E. J., 1995, Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry. Journal of Analytical Toxicology, 19, 18–26.
  • VALLNER, J. J., STEWART, J. T., KOTZAN, J. A., KIRSTEN, E. B. and HONIGBERG, I. L., 1981, Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. Journal of Clinical Pharmacology, 21, 152–156.
  • VENKATESHWARAN, T. G. and STEWART, J. T., 1995, HPLC determination of morphine-hydromorphone-bupivacaine and morphine-hydromorphone-tetracaine mixtures in 0.9% sodium chloride injection. Journal of Liquid Chromatography, 18, 565–578.
  • WETZELSBERGER, N., LIICKER, P. W. and ERKING, W., 1986, High-pressure liquid chromatographic method for the determination of hydromorphone in human plasma with electrochemical detection. Drug Research, 36, 1707–1710.
  • ZHENG, M., MCERLANE, K. M. and ONG, M., 1998, High-performance liquid chromatography-mass spectrometry-mass spectrometry analysis of morphine and morphine metabolites and its application to a pharmacokinetic study in male Sprague—Dawley rats. Journal of Pharmaceutical and Biomedical Analysis, 16, 971–980.
  • ZHENG, M., MCERLANE, K. M. and ONG, M., 2002, Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient. Xenobiotica (in press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.